Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Eli Lilly’s lead in the obesity race gets wider after win against Novo
In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…
Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly
Novo Nordisk stock fell 15% Monday after it said its next-generation weight loss drug didn’t meet its key…